Leading business and finance magazine, Bloomberg Businessweek, featured OurCrowd portfolio company Argo (ReWalk) and quoted OurCrowd’s CEO Jon Medved about investing in medical-device technologies.

Last year [Larry Jasinski] the former Boston Scientific exec became chief executive officer of Argo Medical Technologies, a 42-person startup in Yokneam Illit, Israel. Argo’s main product is the ReWalk, an exoskeleton for helping paraplegics walk again.

In Israel, “we are on the cusp of a golden age of medical-device investment,” says Jonathan Medved, founder and CEO of Jerusalem-based OurCrowd, a crowdfunding site that has invested in Argo. “People sense this is where the money is.”

Read more on Bloomberg Businessweek here.

Argo (ReWalk) raised $1,280,000 from OurCrowd investors in June 2013.